Figiel, Sandy
Yin, Wencheng
Doultsinos, Dimitrios
Erickson, Andrew
Poulose, Ninu
Singh, Reema
Magnussen, Anette
Anbarasan, Thineskrishna
Teague, Renuka
He, Mengxiao
Lundeberg, Joakim
Loda, Massimo
Verrill, Clare
Colling, Richard
Gill, Pelvender S.
Bryant, Richard J.
Hamdy, Freddie C.
Woodcock, Dan J.
Mills, Ian G.
Cussenot, Olivier
Lamb, Alastair D.
Funding for this research was provided by:
Hanson Trust Research
Cancer Research UK
Article History
Received: 12 June 2023
Accepted: 18 September 2023
First Online: 3 October 2023
Declarations
:
: MH and JL are scientific consultants to 10x Genomics, Inc.
: The study was performed according to the Declaration of Helsinki, Basel Declaration and Good Clinical Practice. The study was approved by the Regional Ethical Review Board (REPN) Uppsala, Sweden, before study initiation (Dnr 2011/066/2, Landstinget Västmanland, S. Stenius) and by the Regional Ethical Review Board (EPN), Stockholm, Sweden (DNR 2018/3–31, M. Nistér). All patients were provided with full and adequate verbal and written information about the study before their participation. Written informed consent was obtained from all participating individuals before enrolment in the study.